CXHB2101112 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-09-26 | | Chengdu Suncadia Medicine Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHB2101110 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-09-26 | | Chengdu Suncadia Medicine Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHB2101111 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-09-26 | | Chengdu Suncadia Medicine Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHB2100045 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-23 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2021-03-22 | view |
CXHL1900064 | DDO-3055 | DDO-3055 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2019-02-01 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-01-31 | view |
CXHL1900066 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-02-01 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-01-31 | view |
CXHL1900065 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-02-01 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-01-31 | view |